BlackRock Fund Advisors’s NanoViricides NNVC Stock Holding History
Bought
Maintained
Sold
Other funds holding NNVC
WBG
BCM
RJA
SCA
PTB
BlackRock Fund Advisors's NNVC Position: Q4 2016 in Review
BlackRock Fund Advisors increased its NanoViricides (NNVC) stake by 3.3% in Q4 2016, buying an estimated $4.99K and bringing the position to 5,788 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #3552.
BlackRock Fund Advisors first reported a position in NNVC in Q2 2014 and has held it in 11 quarters since. The position peaked at $4.17M in Q2 2014. 44 funds tracked by Wall St. Rank hold NNVC as of Q4 2016.
- BlackRock Fund Advisors held 5,788 shares of NanoViricides worth $124K as of Q4 2016.
- BlackRock Fund Advisors bought 187 NanoViricides shares in Q4 2016, an estimated $4.99K.
- NanoViricides made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3552 holding.
- BlackRock Fund Advisors first reported a position in NanoViricides in Q2 2014 and has held it in 11 quarters since.
- BlackRock Fund Advisors's NanoViricides position peaked at $4.17M in Q2 2014.
- 44 funds tracked by Wall St. Rank held NanoViricides as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.